Cell Culture Market

Thermo Fisher Scientific (US) is one of the Leading Players in the Cell Culture Market

The cell culture market is expected to reach USD 29.2 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 12.7%. This market is experiencing significant growth due to the increasing demand for monoclonal antibodies, growing preference for single-use technologies, increasing focus on personalized medicine, and rising funding for cell-based research.

The prominent players operating in this market include Thermo Fisher Scientific (US), Merck KGaA (Germany), GE Healthcare (US), Lonza (Switzerland), Becton, Dickinson and Company (US), Corning Incorporated (US), Eppendorf AG (Germany), HiMedia Laboratories (India), Sartorius AG (Germany), PromoCell GmbH (Germany), Danaher Corporation (US), Irvine Scientific (US), InvivoGen (US), and CellGenix GmbH (Germany). Players in this market focused on product launches, partnerships, agreements, collaborations, expansions, and acquisitions to develop and expand their market presence. From 2016 to 2019, product launches was the key growth strategy adopted by players such as Thermo Fisher Scientific, Merck KGaA, and GE Healthcare to enhance their presence in the market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US) is one of the leading players in the cell culture market. This position of the company can be attributed to its strong brand image and robust product portfolio. The company significantly focuses on launching new and advanced products. For instance, in 2018, the company launched its Cell Locker System, Cloud-Enabled Biological Safety Cabinet, and Invitrogen EVOS M7000 Microscope. Also, Thermo Fisher has a major focus on R&D and invested USD 0.97 billion and USD 0.89 billion in R&D in 2018 and 2017, respectively. To increase awareness about its products and offerings, the company has a strong promotional strategy and participates in various trade exhibitions, seminars, and workshops. These factors, coupled with its strong sales force in over 180 countries, have made Thermo Fisher one of the leading players in the cell culture market.

Merck KGaA (Germany) holds a dominant position in the cell culture market. The company has a strong portfolio of cell culture products, including cell culture equipment, cell culture media, reagents, and sera. In order to maintain its strong position in the market, the company focuses on adopting organic as well as inorganic growth strategies such as acquisitions and new product launches. The company’s focus on inorganic growth strategies is evident from its recent collaboration with GenScript (China) to fast-track the commercialization of the cell & gene therapy platform by building a global-standard platform for plasmid and virus manufacturing in China. Furthermore, Merck has a well-organized supply chain, which delivers standard products in 24 to 48 hours worldwide.

GE Healthcare (US) is another leading player in the cell culture market. The company has an exhaustive product portfolio, which includes classical media, specialty media, calf sera, FBS, FBS alternatives, specialty sera, other sera, reagents & supplements, balanced salts, and buffers. GE Healthcare focuses on adopting organic and inorganic business strategies. In May 2018, the company increased its annual production capacity of powdered cell culture media by tenfold. This development strengthened the product supply for biopharmaceutical companies in Europe. The company also doubled its powdered cell culture media manufacturing capacity in the US. In November 2017, GE Healthcare acquired Puridify (UK). This acquisition will help it enhance its production of biopharmaceuticals. Such acquisitions help strengthen the company’s product offerings in the cell culture market.

Related Reports:

Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
BT 2561
RI Published ON
7/1/2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved